Tempus AI, Inc. (NASDAQ:TEM – Get Free Report)’s share price traded down 6.2% on Tuesday . The stock traded as low as $52.04 and last traded at $53.07. 398,629 shares traded hands during mid-day trading, a decline of 67% from the average session volume of 1,198,254 shares. The stock had previously closed at $56.60.
Analyst Ratings Changes
A number of research analysts have issued reports on TEM shares. Loop Capital initiated coverage on Tempus AI in a research note on Tuesday, July 9th. They set a “buy” rating and a $48.00 price objective for the company. TD Cowen initiated coverage on shares of Tempus AI in a research note on Tuesday, July 9th. They set a “buy” rating and a $50.00 price objective for the company. Piper Sandler began coverage on shares of Tempus AI in a research note on Monday, August 12th. They issued a “neutral” rating and a $40.00 target price on the stock. Bank of America initiated coverage on Tempus AI in a research report on Tuesday, July 9th. They issued a “buy” rating and a $41.00 price objective on the stock. Finally, Stifel Nicolaus began coverage on Tempus AI in a report on Tuesday, July 9th. They issued a “buy” rating and a $45.00 target price for the company. One analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $45.56.
Read Our Latest Analysis on Tempus AI
Tempus AI Stock Performance
Tempus AI (NASDAQ:TEM – Get Free Report) last posted its quarterly earnings data on Tuesday, August 6th. The company reported ($6.77) EPS for the quarter, missing the consensus estimate of ($4.41) by ($2.36). The firm had revenue of $165.97 million during the quarter, compared to analysts’ expectations of $159.10 million. On average, equities analysts forecast that Tempus AI, Inc. will post -6.51 EPS for the current fiscal year.
Hedge Funds Weigh In On Tempus AI
A number of hedge funds have recently modified their holdings of TEM. EFG Asset Management North America Corp. bought a new stake in Tempus AI in the 2nd quarter worth approximately $1,333,000. ARK Investment Management LLC purchased a new stake in Tempus AI during the 2nd quarter valued at $18,294,000. Northwestern University bought a new stake in Tempus AI in the second quarter worth $491,000. Alphabet Inc. purchased a new position in Tempus AI during the second quarter worth $54,289,000. Finally, Pier Capital LLC bought a new position in Tempus AI during the second quarter valued at $2,301,000.
About Tempus AI
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
See Also
- Five stocks we like better than Tempus AI
- What Are Dividend Champions? How to Invest in the Champions
- Why Lennar Stock Could Be the Best Play in the Housing Market
- How to Calculate Options Profits
- 2 Energy Stocks Fueling the AI Datacenter Boom
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.